Chemotherapy : Impact Factor & More
eISSN: 1421-9794pISSN: 0009-3157
Share this on:
Key Metrics
CiteScore 
4.5
H-Index
59
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.82
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chemotherapy
Chemotherapy Journal Specifications
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1960 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chemotherapy
Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy.
- 29 Jun 2026
- Chemotherapy
Pseudoprogression of a head and neck cutaneous squamous cell carcinoma treated with anti-PD-1 immunotherapy: a case report and review of the literature.
- 5 Jun 2026
- Chemotherapy
Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A case series.
- 21 May 2026
- Chemotherapy
Efficacy and Safety Study of Different Doses of Linezolid in Combination with Bedaquiline in the Treatment of Drug-Resistant Pulmonary Tuberculosis
- 8 Apr 2026
- Chemotherapy
Can Model-Informed Precision Dosing of Beta-Lactams in Critical Care Improve Clinical Outcomes?
- 3 Feb 2026
- Chemotherapy
Expression of Concern
- 21 Jan 2026
- Chemotherapy
Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy.
- 29 Jun 2026
- Chemotherapy
Pseudoprogression of a head and neck cutaneous squamous cell carcinoma treated with anti-PD-1 immunotherapy: a case report and review of the literature.
- 5 Jun 2026
- Chemotherapy
Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A case series.
- 21 May 2026
- Chemotherapy
Efficacy and Safety Study of Different Doses of Linezolid in Combination with Bedaquiline in the Treatment of Drug-Resistant Pulmonary Tuberculosis
- 8 Apr 2026
- Chemotherapy
Can Model-Informed Precision Dosing of Beta-Lactams in Critical Care Improve Clinical Outcomes?
- 3 Feb 2026
- Chemotherapy
Expression of Concern
- 21 Jan 2026
- Chemotherapy
FAQs on Chemotherapy
How long has Chemotherapy been actively publishing? 
What is the publishing frequency of Chemotherapy?
How many articles did Chemotherapy publish last year?
What is the eISSN & pISSN for Chemotherapy?
What is Citescore for Chemotherapy?
What is the H Index for Chemotherapy ?
What is SNIP score for Chemotherapy?
What is the SJR for Chemotherapy?
Who is the publisher of Chemotherapy?
